Affordable Access

Booster vaccination of toddlers with reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

Authors
  • Nolan, Terry
  • Ruff, Tilman A.
  • Lambert, Stephen B.
  • Buttery, Jim
  • O'Grady, Kerry-Ann
  • Streeton, Catherine
  • Hoet, Bernard
  • Bock, Hans L.
Publication Date
Jan 01, 2009
Source
Queensland University of Technology ePrints Archive
Keywords
License
Unknown
External links

Abstract

Immunogenicity and reactogenicity of DTPa and reduced antigen dTpa booster vaccines were compared to a hepatitis A control vaccine in DTPa-primed toddlers aged 18-20 months. Post-booster, all DTPa and dTpa recipients were seroprotected against diphtheria and tetanus, and >= 93.3% had a booster response to pertussis. There were similar reactogenicity rates in the DTPa and dTpa vaccine recipients. Few Grade 3 symptoms were reported. Just over one in four children in the control group had diphtheria antibody at or potentially below the correlate of protection benchmark (0.016 IU/ml). Larger studies should evaluate potential benefits of reduced antigen vaccines and seroprotection in children who do not receive a booster dose of DTPa at this age, including protection against diphtheria until subsequent booster doses are given. (C) 2009 Elsevier Ltd. All rights reserved.

Report this publication

Statistics

Seen <100 times